Literature DB >> 28902411

Functional changes in the neural retina occur in the absence of mitochondrial dysfunction in a rodent model of diabetic retinopathy.

Dustin R Masser1,2, Laura Otalora1,3,4, Nicholas W Clark1,3, Michael T Kinter4,5, Michael H Elliott6, Willard M Freeman1,2,3,4.   

Abstract

Diabetic retinopathy is a neurovascular diabetes complication resulting in vision loss. A wealth of literature reports retinal molecular changes indicative of neural deficits, inflammation, and vascular leakage with chronic diabetes, but the mechanistic causes of disease initiation and progression are unknown. Microvascular mitochondrial DNA (mtDNA) damage leading to mitochondrial dysfunction has been proposed to drive vascular dysfunction in retinopathy. However, growing evidence suggests that neural retina dysfunction precedes and may cause vascular damage. Therefore, we tested the hypothesis that neural mtDNA damage and mitochondrial dysfunction are an early initiating factor of neural diabetic retinopathy development in a rat streptozotocin-induced, Type I diabetes model. Mitochondrial function (oxygen consumption rates) was quantified in retinal synaptic terminals from diabetic and non-diabetic rats with paired retinal structural and function assessment (optical coherence tomography and electroretinography, respectively). Mitochondrial genome damage was assessed by identifying mutations and deletions across the mtDNA genome by high depth sequencing and absolute mtDNA copy number counting through digital PCR. Mitochondrial protein expression was assessed by targeted mass spectrometry. Retinal functional deficits and neural anatomical changes were present after 3 months of diabetes and prevented/normalized by insulin treatment. No marked dysfunction of mitochondrial activity, maladaptive changes in mitochondrial protein expression, alterations in mtDNA copy number, or increase in mtDNA damage was observed in conjunction with retinal functional and anatomical changes. These results demonstrate that neural retinal dysfunction with diabetes begins prior to mtDNA damage and dysfunction, and therefore retinal neurodegeneration initiation with diabetes occurs through other, non-mitochondrial DNA damage, mechanisms.
© 2017 International Society for Neurochemistry.

Entities:  

Keywords:  diabetes; diabetic retinopathy; insulin; mitochondria; mtDNA; retina

Mesh:

Substances:

Year:  2017        PMID: 28902411      PMCID: PMC5693713          DOI: 10.1111/jnc.14216

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  45 in total

Review 1.  Diabetic retinopathy is a neurodegenerative disorder.

Authors:  Stephanie K Lynch; Michael D Abràmoff
Journal:  Vision Res       Date:  2017-04-28       Impact factor: 1.886

2.  Normal levels of wild-type mitochondrial DNA maintain cytochrome c oxidase activity for two pathogenic mitochondrial DNA mutations but not for m.3243A-->G.

Authors:  Steve E Durham; David C Samuels; Lynsey M Cree; Patrick F Chinnery
Journal:  Am J Hum Genet       Date:  2007-05-23       Impact factor: 11.025

3.  Mitochondrial DNA exhibits resistance to induced point and deletion mutations.

Authors:  William J Valente; Nolan G Ericson; Alexandra S Long; Paul A White; Francesco Marchetti; Jason H Bielas
Journal:  Nucleic Acids Res       Date:  2016-08-22       Impact factor: 16.971

4.  Insulin treatment normalizes retinal neuroinflammation but not markers of synapse loss in diabetic rats.

Authors:  Dustin R Masser; Heather D VanGuilder Starkey; Georgina V Bixler; Wendy Dunton; Sarah K Bronson; Willard M Freeman
Journal:  Exp Eye Res       Date:  2014-06-12       Impact factor: 3.467

5.  An overview of randomization techniques: An unbiased assessment of outcome in clinical research.

Authors:  Kp Suresh
Journal:  J Hum Reprod Sci       Date:  2011-01

6.  Chronic insulin treatment of diabetes does not fully normalize alterations in the retinal transcriptome.

Authors:  Georgina V Bixler; Heather D Vanguilder; Robert M Brucklacher; Scot R Kimball; Sarah K Bronson; Willard M Freeman
Journal:  BMC Med Genomics       Date:  2011-05-15       Impact factor: 3.063

Review 7.  The progress in understanding and treatment of diabetic retinopathy.

Authors:  Alan W Stitt; Timothy M Curtis; Mei Chen; Reinhold J Medina; Gareth J McKay; Alicia Jenkins; Thomas A Gardiner; Timothy J Lyons; Hans-Peter Hammes; Rafael Simó; Noemi Lois
Journal:  Prog Retin Eye Res       Date:  2015-08-18       Impact factor: 21.198

8.  Topical administration of somatostatin prevents retinal neurodegeneration in experimental diabetes.

Authors:  Cristina Hernández; Marta García-Ramírez; Lidia Corraliza; Jimena Fernández-Carneado; Josep Farrera-Sinfreu; Berta Ponsati; Agueda González-Rodríguez; Angela M Valverde; Rafael Simó
Journal:  Diabetes       Date:  2013-03-08       Impact factor: 9.461

9.  Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC.

Authors:  John M Lachin; Neil H White; Dean P Hainsworth; Wanjie Sun; Patricia A Cleary; David M Nathan
Journal:  Diabetes       Date:  2014-09-09       Impact factor: 9.461

Review 10.  The dynamics of mitochondrial DNA heteroplasmy: implications for human health and disease.

Authors:  James B Stewart; Patrick F Chinnery
Journal:  Nat Rev Genet       Date:  2015-09       Impact factor: 53.242

View more
  12 in total

Review 1.  Retinal Neurodegeneration as an Early Manifestation of Diabetic Eye Disease and Potential Neuroprotective Therapies.

Authors:  Sidra Zafar; Mira Sachdeva; Benjamin J Frankfort; Roomasa Channa
Journal:  Curr Diab Rep       Date:  2019-02-26       Impact factor: 4.810

Review 2.  Spermine oxidase: A promising therapeutic target for neurodegeneration in diabetic retinopathy.

Authors:  S Priya Narayanan; Esraa Shosha; Chithra D Palani
Journal:  Pharmacol Res       Date:  2019-06-15       Impact factor: 7.658

Review 3.  Therapeutic targets for altering mitochondrial dysfunction associated with diabetic retinopathy.

Authors:  Renu A Kowluru; Manish Mishra
Journal:  Expert Opin Ther Targets       Date:  2018-03       Impact factor: 6.902

Review 4.  Mitophagy in Human Diseases.

Authors:  Laura Doblado; Claudia Lueck; Claudia Rey; Alejandro K Samhan-Arias; Ignacio Prieto; Alessandra Stacchiotti; Maria Monsalve
Journal:  Int J Mol Sci       Date:  2021-04-09       Impact factor: 5.923

Review 5.  Diabetic Retinopathy: The Role of Mitochondria in the Neural Retina and Microvascular Disease.

Authors:  David J Miller; M Ariel Cascio; Mariana G Rosca
Journal:  Antioxidants (Basel)       Date:  2020-09-23

6.  Characterisation of impaired wound healing in a preclinical model of induced diabetes using wide-field imaging and conventional immunohistochemistry assays.

Authors:  Mayer Saidian; Jonathan R T Lakey; Adrien Ponticorvo; Rebecca Rowland; Melissa Baldado; Joshua Williams; Maaikee Pronda; Michael Alexander; Antonio Flores; Li Shiri; Stellar Zhang; Bernard Choi; Roni Kohen; Bruce J Tromberg; Anthony J Durkin
Journal:  Int Wound J       Date:  2018-10-01       Impact factor: 3.315

7.  Intravitreal pro-inflammatory cytokines in non-obese diabetic mice: Modelling signs of diabetic retinopathy.

Authors:  Odunayo O Mugisho; Ilva D Rupenthal; David M Squirrell; Sarah J Bould; Helen V Danesh-Meyer; Jie Zhang; Colin R Green; Monica L Acosta
Journal:  PLoS One       Date:  2018-08-22       Impact factor: 3.240

8.  Type 2 diabetes-induced hyposalivation of the submandibular gland through PINK1/Parkin-mediated mitophagy.

Authors:  Ruo-Lan Xiang; Yan Huang; Yan Zhang; Xin Cong; Zhe-Jing Zhang; Li-Ling Wu; Guang-Yan Yu
Journal:  J Cell Physiol       Date:  2019-06-12       Impact factor: 6.384

9.  Mitochondrial oxidative stress impairs contractile function but paradoxically increases muscle mass via fibre branching.

Authors:  Bumsoo Ahn; Rojina Ranjit; Pavithra Premkumar; Gavin Pharaoh; Katarzyna M Piekarz; Satoshi Matsuzaki; Dennis R Claflin; Kaitlyn Riddle; Jennifer Judge; Shylesh Bhaskaran; Kavithalakshmi Satara Natarajan; Erika Barboza; Benjamin Wronowski; Michael Kinter; Kenneth M Humphries; Timothy M Griffin; Willard M Freeman; Arlan Richardson; Susan V Brooks; Holly Van Remmen
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-02-01       Impact factor: 12.910

10.  Risk factors and prevalence of diabetic retinopathy: A protocol for meta-analysis.

Authors:  Yuying Hou; Yitong Cai; Zhumin Jia; Suling Shi
Journal:  Medicine (Baltimore)       Date:  2020-10-16       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.